Darwin Global Management, Ltd. Astrazeneca PLC Transaction History

Darwin Global Management, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $151 Million - $387 Million	-2,849,109 Closed	0 $0
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $70.4 Million - $84.5 Million	1,187,425 Added 71.46%	2,849,109 $188 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $64.1 Million - $77.2 Million	1,149,776 Added 224.61%	1,661,684 $110 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $27.7 Million - $32.7 Million	511,908 New	511,908 $29.8 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.